Understanding the nanotechnology in COVID-19 vaccines

by CAS, a division of the American Chemical Society

11 hours ago
nanotechnology, covid19, vaccines

Lipid nanoparticles are a vital component of the new Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines, playing a key role in protecting and transporting the mRNA effectively to the right place in ce...

Pall Corporation Invests $114M to Expand Global Production Capacity

by Pall Biotech

2 months ago
covid-19, Invests, Pall, production capacity, manufacturing solutions, vaccines, genes therapies

Pall Corporation expands production capacity in the United States and Europe to support industry demand

Oh, what a year it’s been! Lessons learned amid the pandemic

by CAS, a division of the American Chemical Society

2 months ago
scientists, lessons, pandemic, covid-19, vaccines

We began 2020 refreshed and hopeful, with plans to publish unique perspectives and insights to inspire new ideas in the months to come—but COVID-19 changed everything. As the world adapted and recon...

Daniel Bravo Foundation and ISGlobal Launch Major Research Project on Immunology of Emerging Diseases

by ISGlobal - Instituto de Salud Global de Barcelona

5 months ago
vaccines, Emerging Diseases, Immunology, covid-19

The collaboration arose from the need to better understand and protect against the spread of COVID-19

Sartorius raises forecast for the full year of 2020

by Sartorius

7 months ago
antiviral medications, growth, profitability, Bioprocess Solutions Division, coronavirus, vaccines

Stronger growth and higher profitability expected for the Bioprocess Solutions Division and the entire Group; outlook for the Lab Products & Services Division unchanged

Telstar MSC in TV NBC News report

by Telstar

9 months ago
covid-19, vaccines, microbiological safety cabinets, NBC News

Telstar microbiological safety cabinets are present in the most prominent laboratories around the world which are working on the research for vaccines to treat or prevent Covid-19.

Molecular Signatures Can Predict the Efficacy of Malaria Vaccines

by ISGlobal - Instituto de Salud Global de Barcelona

10 months ago
vaccines, malaria, biomarker

A new study reveals that it is possible to identify those individuals that will be protected by the vaccine before its administration

Pulmobiotics secures two-million-euro investment from Invivo Capital

by Centre for Genomic Regulation

11 months ago
synthetic biology, vaccines, Pulmobiotics S.L, lung diseases

Luis Serrano and Maria Lluch of the Centre for Genomic Regulation (CRG) in Barcelona have founded Pulmobiotics S.L., a pre-clinical life sciences company using synthetic biology to develop new treatme...

Designing multi-purpose vaccines: the MycoSynVac project concludes after five years

by Centre for Genomic Regulation

11 months ago
vaccines, MycoSynVac, Mycoplasma, bioengineering

Scientists from the five-year EU funded project MycoSynVac report their findings and successes at a final meeting in Brussels. The project drew on cutting edge biotechnology to explore three important...

Nine Million Children Could Die in a Decade Unless World Acts on Pneumonia, Leading Agencies Warn

by ISGlobal - Instituto de Salud Global de Barcelona

1 year ago
childhood pneumonia, vaccines, Pneumonia

Today starts the first ever global forum on childhood pneumonia in Barcelona, organised by the Barcelona Institute for Global Health together with eight international entities

The manufacturing process for Strangvac, the new vaccine against equine strangles, is proceeding according to plan

by 3P Biopharmaceuticals

2 years ago
Praxis Pharmaceuticals, Strangvac, 3P Biopharmaceutical, vaccines, proteins

The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, finalized the production of the drug substances on a commercial scale in complian...